Hiding under the skin: Interleukin-17–producing γδ T cells go under the skin?
- 6 December 2012
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 18 (12) , 1748-1750
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Discontinued drugs 2011: pulmonary, allergy, gastrointestinal and arthritisExpert Opinion on Investigational Drugs, 2012
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque PsoriasisNew England Journal of Medicine, 2012
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for PsoriasisNew England Journal of Medicine, 2012
- PsoriasisAnnual Review of Pathology: Mechanisms of Disease, 2012
- Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasisBritish Journal of Dermatology, 2011
- A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti–interferon-alfa monoclonal antibody, in subjects with chronic psoriasisJournal of the American Academy of Dermatology, 2010
- Comparison of Ustekinumab and Etanercept for Moderate-to-Severe PsoriasisNew England Journal of Medicine, 2010
- APC-derived cytokines and T cell polarization in autoimmune inflammationJournal of Clinical Investigation, 2007
- Psoriasis Triggered by Toll-like Receptor 7 Agonist Imiquimod in the Presence of Dermal Plasmacytoid Dendritic Cell PrecursorsArchives of Dermatology, 2004
- Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-αJournal of Experimental Medicine, 2004